arrow
V

Vanessa Contreras

institut national de la santé et de la recherche médicale (inserm)
H指数:23
被引数:2,814

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing

法匹拉韦的组织分布和抑制倍数在临床前模型中:迈向循证抗病毒药物重定位的流程

2026-07-030
OAAI
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates

非人灵长类中无佐剂CD40靶向SARS-CoV-2疫苗的免疫原性和保护效力

2026-07-010
OA
Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates

通过免疫PET成像对非人灵长类动物体内SARS-CoV-2生物分布进行全身可视化

2025-03-210
OA
Multimodal mucosal and systemic immune characterization of a non-human primate trachoma model highlights the critical role of local immunity during acute phase disease

非人类灵长类动物沙眼模型的多模式粘膜和全身免疫表征突出了局部免疫在急性期疾病中的关键作用

2024-08-020
OAAI
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
2024-04-031
OA
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
2023-12-012
OA
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
2022-08-3020
OAAI
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection

用合成SARS-CoV-2 S糖蛋白病毒样颗粒预防接种保护猕猴免受感染

2022-02-015
OAAI
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
2021-10-2033
OAAI
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
2021-09-0125
OAAI
Non-human primate models of human respiratory infections

人类呼吸道感染的非人灵长类动物模型

2021-07-0124
OAAI
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota
2021-03-0864
OAAI
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity
2021-02-2423
OAAI